References
1. Arowolo, K.O., et al., Epidemiology of enteric viruses in
children with gastroenteritis in Ogun State, Nigeria.
Journal of medical virology, 2019. 91(6): p. 1022-1029.
2. Yang, H., et al., The distinct impact of maternal antibodies
on the immunogenicity of live and recombinant rotavirus
vaccines. Vaccine, 2019. 37(30): p. 4061-4067.
3. Guarino, A., et al., European Society for Pediatric
Gastroenterology, Hepatology, and Nutrition/European
Society for Pediatric Infectious Diseases evidence-based
guidelines for the management of acute gastroenteritis in
children in Europe: update 2014. Journal of pediatric
gastroenterology and nutrition, 2014. 59(1): p. 132-152.
4. Honda, M., et al., Liposomes and nanotechnology in drug
development: focus on ocular targets. International journal
of nanomedicine, 2013: p. 495-504.
5. Gwinn, M.R. and V. Vallyathan, Nanoparticles: health
effects—pros and cons. Environmental health perspectives,
2006. 114(12): p. 1818-1825.
6. Mukherjee, S. and C.R. Patra, Biologically synthesized
metal nanoparticles: recent advancement and future
perspectives in cancer theranostics. 2017, Future Science.
p. FSO203.
7. Ghosh, S. and A. Ghosh, Next-generation optical
nanotweezers for dynamic manipulation: from surface to
bulk. Langmuir, 2020. 36(21): p. 5691-5708.
8. Jain, N., et al., Removal of protein capping enhances the
antibacterial efficiency of biosynthesized silver
nanoparticles. PLoS One, 2015. 10(7): p. e0134337.
9. Akhtar, M.J., et al., Dose-dependent genotoxicity of copper
oxide nanoparticles stimulated by reactive oxygen species
in human lung epithelial cells. Toxicology and industrial
health, 2016. 32(5): p. 809-821.
10. Hang, X., et al., Antiviral activity of cuprous oxide
nanoparticles against Hepatitis C Virus in vitro. Journal of
virological methods, 2015. 222: p. 150-157.
11. Tavakoli, A. and M.S. Hashemzadeh, Inhibition of herpes
simplex virus type 1 by copper oxide nanoparticles. Journal
of virological methods, 2020. 275: p. 113688.
12. Fujimori, Y., et al., Novel antiviral characteristics of
nanosized copper (I) iodide particles showing inactivation
activity against 2009 pandemic H1N1 influenza virus.
Applied and Environmental Microbiology, 2012. 78(4): p.
951-955.
13. Tortella, G., et al., Silver, copper and copper oxide
nanoparticles in the fight against human viruses: progress
and perspectives. Critical Reviews in Biotechnology, 2022.
42(3): p. 431-449.
14. Hosseini, Z., et al., The human cathelicidin LL-37, a
defensive peptide against rotavirus infection. International
Journal of Peptide Research and Therapeutics, 2020. 26: p.
911-919.
15. Vimbela, G.V., et al., Antibacterial properties and
toxicity from metallic nanomaterials. International journal
of nanomedicine, 2017. 12: p. 3941.
16. Chatterjee, A.K., R. Chakraborty, and T. Basu,
Mechanism of antibacterial activity of copper
nanoparticles. Nanotechnology, 2014. 25(13): p. 135101.
17. Warnes, S.L., E.N. Summersgill, and C.W. Keevil,
Inactivation of murine norovirus on a range of copper alloy
surfaces is accompanied by loss of capsid integrity.
Applied and Environmental Microbiology, 2015. 81(3): p.
1085-1091.
18. Warnes, S.L. and C.W. Keevil, Inactivation of norovirus
on dry copper alloy surfaces. PloS one, 2013. 8(9): p.
e75017.